Why the study?
What are the current conventional and newer therapies for the prevention and treatment of perioperative myocardial ischemia?
What are the current conventional and newer therapies for the prevention and treatment of perioperative myocardial ischemia?
This review outlines the management of perioperative myocardial ischemia, emphasizing the balance of myocardial oxygen supply and demand through conventional and emerging therapies.
Emphasizes supply-demand optimization for perioperative ischemia; extends conventional therapies with emerging options but leaves efficacy open pending trials.
Prevention and treatment of myocardial ischemia re mains a central focus of perioperative care. Myocardial ischemia is best understood in terms of myocardial oxygen supply and demand ratios. Conventional ther apy includes nitrates, β-blockers, and calcium channel blockers. In all 3 drug classes, ischemia is reduced by either improving supply, decreasing demand, or both. More recent investigation evaluates these medications either as prophylactic therapy or as a component of long-term risk reduction for cardiac morbid events. Newer therapies, including anticoagulation, pain ther apy, normothermia, central neuroaxial techniques, and other therapies, are reviewed.
No takes yet. Share an insight, caveat, or question.
David A. Zvara (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: